Abbott Laboratories (ABT), the global healthcare titan, announced on Dec. 22 that the U.S. Food and Drug Administration (FDA) has approved its Volt™ PFA System for treating atrial fibrillation (AFib).

Shoulder Innovations' revenue guidance was raised to $45.5M for 2025, with Q3 sales up 58% YoY and sequential growth expected ...

Calvert-Lewin’s is by far the smallest, represented by the shaded black area. The list is dominated by target-man strikers, ...

Here are the 2025 ZIPS projections. And here are the 2026 ZIPS projections. The top line of this is simple, 2026 ZiPS likes ...

On December 16, BofA analyst Vivek Arya raised the firm’s price target on Texas Instruments Incorporated (NASDAQ:TXN) to $185 ...

Yadier del Valle ripped through Isaac Dulgarian on Saturday – but the betting sharps have an eyebrow raised. Minutes before the fighters involved walked to the cage at UFC Fight Night 263, del Valle ...

Learn how Marc Chaikin's Money Flow Indicator uses price and volume data for better trading decisions, highlighting ...

Cruise ship company Carnival (NYSE:CCL) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 6.6% year on year to $6.33 billion. Its non-GAAP profit of $0.34 per share was 38.6% ...

Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...

Goalie Trey Augustine and freshman Porter Martone are two reasons the MSU hockey team has been among the nation's best during ...

RH’s third quarter results were shaped by ongoing investments in international expansion and persistent tariff-related ...